UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Journal of hematology and oncology, 2018-01, Vol.11 (1), p.15-15, Article 15

2018

Volltextzugriff (PDF)

Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma

Nature communications, 2019-09, Vol.10 (1), p.4209-14, Article 4209

2019

Volltextzugriff (PDF)

Recurrent PDGFRB mutations in unicentric Castleman disease

Leukemia, 2019-04, Vol.33 (4), p.1035-1038

2019

Volltextzugriff (PDF)

TBI/Cy followed by auto-HSCT is a good choice next to allo-HSCT for patients with T-LBL/ALL

Scientific reports, 2024-09, Vol.14 (1), p.22356-9, Article 22356

2024

Volltextzugriff (PDF)

Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction

Journal of experimental & clinical cancer research, 2010-06, Vol.29 (1), p.80-80, Article 80

2010

Volltextzugriff (PDF)

MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line

Biochemical and biophysical research communications, 2011-01, Vol.404 (1), p.273-278

2011

Volltextzugriff (PDF)

Strategies to overcome CAR-T cell resistance in clinical work: A single-institute experience

Frontiers in immunology, 2022-08, Vol.13, p.929221-929221

2022

Volltextzugriff (PDF)

First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3026-3026

2020

Volltextzugriff (PDF)

AEG-1 is involved in hypoxia-induced autophagy and decreases chemosensitivity in T-cell lymphoma

Molecular medicine (Cambridge, Mass.), 2018-07, Vol.24 (1), p.35-35, Article 35

2018

Volltextzugriff (PDF)

Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma

Haematologica (Roma), 2020-03, Vol.105 (3), p.e107-e110

2020

Volltextzugriff (PDF)

Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920923829

2020

Volltextzugriff (PDF)

Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study

Indian journal of hematology & blood transfusion, 2022-01, Vol.38 (1), p.42-50

2022

Volltextzugriff (PDF)

MicroRNA expression analysis of mammospheres cultured from human breast cancers

Journal of cancer research and clinical oncology, 2012-11, Vol.138 (11), p.1937-1944

2012

Volltextzugriff (PDF)

Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial

Cancer biology & medicine, 2021-10, Vol.19 (7), p.1089-1099

2021

Volltextzugriff (PDF)

Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?

Cancer cell international, 2018-10, Vol.18 (1), p.150-150, Article 150

2018

Volltextzugriff (PDF)

Safety and efficacy of low-dose pre-phase before conventional-dose chemotherapy for ulcerative gastric diffuse large B-cell lymphoma

Leukemia & lymphoma, 2015-01, Vol.56 (9), p.2613-2618

2015

Volltextzugriff (PDF)

DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

Clinical cancer research, 2016-11, Vol.22 (21), p.5223-5228

2016

Volltextzugriff (PDF)

Autologous nanobody-derived fratricide-resistant CD7-CAR T cell therapy for patients with relapsed and refractory T-cell acute lymphoblastic leukemia/lymphoma

Clinical cancer research, 2022-07, Vol.28 (13), p.2830-2843

2022

Volltextzugriff (PDF)

CD5-positive marginal zone lymphoma: Clinicopathological features and survival outcomes

Leukemia research, 2022-06, Vol.117, p.106840-106840, Article 106840

2022

Volltextzugriff (PDF)

MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1

Cancer biology & therapy, 2019-01, Vol.20 (1), p.31-41

2019

Volltextzugriff (PDF)

Efficacy and Safety of Chemotherapy (DDGP vs VIPD) Followed Radiotherapy Vs Radiotherapy Followed Chemotherapy (DDGP vs VIPD) Vs Radiotherapy Alone for Newly Diagnosed Early Stage Extranodal Natural Killer/T Cell Lymphoma: Final Results of a Prospective, Multicenter, Randomized, Controlled Clinical Trial

Blood, 2023-11, Vol.142 (Supplement 1), p.1690-1690

2023

Volltextzugriff (PDF)

Anti-PD-1-Antibody (Tislelizumab) Combined with Deacetylase Inhibitor (Chidamide), Lenalidomide and Etoposide for the Treatment of Refractory/Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r-ENKTL): Preliminary Results from a Prospective, Multicenter, Single -Arm, Phase II Trial

Blood, 2021-11, Vol.138 (Supplement 1), p.1368-1368

2021

Volltextzugriff (PDF)

Six1 mediates resistance to paclitaxel in breast cancer cells

Biochemical and biophysical research communications, 2013-11, Vol.441 (3), p.538-543

2013

Volltextzugriff (PDF)

Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T‐cell lymphoma: A randomized, controlled, open‐label, multicenter study

International journal of cancer, 2021-03, Vol.148 (6), p.1470-1477

2021

Volltextzugriff (PDF)

Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial

Journal of neuro-oncology, 2018-11, Vol.140 (2), p.427-434

2018

Volltextzugriff (PDF)

1 – 25 von 255

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(234)
Mit Volltextzugriff
(231)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(193)
Life Sciences & Biomedicine
(126)
Humans
(62)
Physical Sciences
(47)
Technology
(40)
Oncology
(38)
Female
(34)
Chemistry
(29)
Animals
(28)
Male
(26)
Materials Science
(22)
Lymphoma
(20)
Materials Science, Multidisciplinary
(19)
Biochemistry & Molecular Biology
(17)
Hematology
(17)
Mice
(17)
Chemotherapy
(16)
Gene Expression
(16)
Middle Aged
(16)
Science & Technology - Other Topics
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma

Recurrent PDGFRB mutations in unicentric Castleman disease

TBI/Cy followed by auto-HSCT is a good choice next to allo-HSCT for patients with T-LBL/ALL

Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction

MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line

Strategies to overcome CAR-T cell resistance in clinical work: A single-institute experience

First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma

AEG-1 is involved in hypoxia-induced autophagy and decreases chemosensitivity in T-cell lymphoma

Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma

Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients

Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study

MicroRNA expression analysis of mammospheres cultured from human breast cancers

Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial

Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?

Safety and efficacy of low-dose pre-phase before conventional-dose chemotherapy for ulcerative gastric diffuse large B-cell lymphoma

DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

Autologous nanobody-derived fratricide-resistant CD7-CAR T cell therapy for patients with relapsed and refractory T-cell acute lymphoblastic leukemia/lymphoma

CD5-positive marginal zone lymphoma: Clinicopathological features and survival outcomes

MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1

Anti-PD-1-Antibody (Tislelizumab) Combined with Deacetylase Inhibitor (Chidamide), Lenalidomide and Etoposide for the Treatment of Refractory/Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r-ENKTL): Preliminary Results from a Prospective, Multicenter, Single -Arm, Phase II Trial

Six1 mediates resistance to paclitaxel in breast cancer cells

Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T‐cell lymphoma: A randomized, controlled, open‐label, multicenter study

Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial

Suchergebnisse filtern